Borghese Bruno, Chiche Jean-Daniel, Vernerey Déwi, Chenot Claire, Mir Olivier, Bijaoui Gérard, Bonaiti-Pellié Catherine, Chapron Charles
Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Service de Gynécologie-Obstétrique II, CHU Cochin-Saint Vincent de Paul, Paris, France.
Hum Reprod. 2008 May;23(5):1207-13. doi: 10.1093/humrep/den007. Epub 2008 Feb 28.
Matrix metalloproteinases (MMPs) may contribute to endometriosis. We tested whether eight functional polymorphisms of these genes could modify the risk of endometriosis.
In this case-control study, 227 endometriosis and 241 controls were genotyped for MMP1 -1607 1G/2G, MMP2 -1575 G/A (MMP2.1), -1306 C/T (MMP2.2), MMP3 -1612 5A/6A, MMP7 -153 C/T (MMP7.1), -181 A/G (MMP7.2), MMP12 -82 A/G and MMP13-77 A/G. Association between MMP genotypes and superficial (SUP), deep infiltrating (DIE) and endometriomas (OMA) was tested for each polymorphism separately, using unconditional logistic regression and then for combined genotypes, using the combination test.
When considering all cases, MMP2 polymorphisms were found to be significant, mainly due to DIE (P = 0.023). A small difference between SUP and controls was found for MMP7.2 (P = 0.032) and MMP12 (P = 0.035), in the absence of correction for multiple testing. Using the combination test, the best association when comparing SUP with controls was obtained for MMP12-MMP13 (P = 0.004) for the combined genotype A/G-A/A (odds ratio = 27.60, 95% confidence interval: 2.80-272.40).
These data show a potential role for MMP12 -82 A/G and MMP13 -77 A/G combined polymorphisms in superficial endometriosis. As no association was found with deep infiltrating endometriosis, this combination of polymorphisms might protect from a more in-depth penetration of tissues.
基质金属蛋白酶(MMPs)可能与子宫内膜异位症有关。我们测试了这些基因的八个功能多态性是否会改变子宫内膜异位症的风险。
在这项病例对照研究中,对227例子宫内膜异位症患者和241例对照进行了MMP1 -1607 1G/2G、MMP2 -1575 G/A(MMP2.1)、-1306 C/T(MMP2.2)、MMP3 -1612 5A/6A、MMP7 -153 C/T(MMP7.1)、-181 A/G(MMP7.2)、MMP12 -82 A/G和MMP13 -77 A/G的基因分型。分别使用无条件逻辑回归对每个多态性检测MMP基因型与浅表性(SUP)、深部浸润性(DIE)和卵巢子宫内膜异位囊肿(OMA)之间的关联,然后使用联合检验对组合基因型进行检测。
在考虑所有病例时,发现MMP2多态性具有显著性,主要归因于深部浸润性子宫内膜异位症(P = 0.023)。在未进行多重检验校正的情况下,发现MMP7.2(P = 0.032)和MMP12(P = 0.035)在浅表性子宫内膜异位症与对照之间存在微小差异。使用联合检验,在比较浅表性子宫内膜异位症与对照时,组合基因型A/G-A/A的MMP12-MMP13获得了最佳关联(P = 0.004)(比值比 = 27.60,95%置信区间:2.80 - 272.40)。
这些数据表明MMP12 -82 A/G和MMP13 - /77 A/G联合多态性在浅表性子宫内膜异位症中具有潜在作用。由于未发现与深部浸润性子宫内膜异位症有关联,这种多态性组合可能有助于防止组织的更深入浸润。